Wednesday, May 21, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News
Home Developments

GlaxoSmithKline and Pfizer to form new Consumer Healthcare Joint Venture in Merger

IPN by IPN
19 December 2018
in Developments, Product News
0
GlaxoSmithKline (GSK) has announced plans to split its prescription and vaccination operations and it’s over-the-counter operations into two separate businesses after announcing a merge venture with global rivals Pfizer.
Today GSK CEO, Emma Walmsley announced that GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of €10.8 billion, 68 per cent-owned by the British company, in an all-equity transaction and 32 per cent owned by Pfizer.

#NEWS: Today, we have reached an agreement with @Pfizer to form a new world-leading Consumer Healthcare Joint Venture.

Read more: https://t.co/a5Cfg5A75H $GSK $PFE pic.twitter.com/dxRgCMax0w

— GSK (@GSK) 19 December 2018

Emma Walmsley, Chief Executive Officer, GSK, said: “Ultimately, our goal is to create two exceptional, UK-based global companies, with appropriate capital structures, that are each well positioned to deliver improving returns to shareholders and significant benefits to patients and consumers.”

The deal for Pfizer provides a solution for the future of  its consumer health department, which includes Advil painkillers and Centrum vitamins, after making an attempt to sell it earlier in the year.

This new merger with Pfizer is expected to generate total annual cost savings of €554 million by 2022 for expected total cash costs of €998 million and non-cash charges of €333 million. GSK plans divestments of some €1+ billion.

The proposed transaction is subject to approval by GSK shareholders and conditional upon the receipt of certain anti-trust authority approvals. Subject to these approvals, the transaction is expected to close in the second half of 2019. The Board intends to recommend that GSK shareholders vote in favour of the proposed transaction.

Tags: GSKIrelandPfizer
Previous Post

LloydsPharmacy announced as winner of InBUSINESS Recognition Award for Retail Excellence

Next Post

Minister for Health makes neonatal Herpes a notifiable disease

Next Post

Minister for Health makes neonatal Herpes a notifiable disease

Leave a Reply

Your email address will not be published. Required fields are marked *

wins

ALFLOREX® WINS AT IRISH PHARMACY NEWS OTC AWARDS FOR NINTH YEAR IN A ROW

20 May 2025
Blackberry hearing secures Uniphar deal

Blackberry hearing secures Uniphar deal

15 May 2025
Clonmel Healthcare Announces Donagh O’Leary as Managing Director

Clonmel Healthcare Announces Donagh O’Leary as Managing Director

15 May 2025

RECOMMENDED NEWS

Urinary Tract Infections

Urinary Tract Infections

4 years ago
Finalists in Best Cough, Cold and Flu Product 2024

Finalists in Best Cough, Cold and Flu Product 2024

1 year ago

Offaly Pharmacist urges those who believe they have been exposed to HIV to consult their doctor

7 years ago
‘Sunshine Vitamin under the Spotlight’

‘Sunshine Vitamin under the Spotlight’

4 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Follow us on social media:

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login